Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/105750
DC Field | Value | Language |
---|---|---|
dc.contributor | School of Optometry | en_US |
dc.contributor | Research Institute for Smart Ageing | en_US |
dc.creator | Barathi, VA | en_US |
dc.creator | Katz, A | en_US |
dc.creator | Chaudhary, S | en_US |
dc.creator | Li, HL | en_US |
dc.creator | Tal, DM | en_US |
dc.creator | Marcovich,AL | en_US |
dc.creator | Do, CW | en_US |
dc.creator | Karlish, SJD | en_US |
dc.date.accessioned | 2024-04-16T06:01:21Z | - |
dc.date.available | 2024-04-16T06:01:21Z | - |
dc.identifier.issn | 0363-6143 | en_US |
dc.identifier.uri | http://hdl.handle.net/10397/105750 | - |
dc.language.iso | en | en_US |
dc.publisher | American Physiological Society | en_US |
dc.rights | © 2024 The Authors. Licensed under Creative Commons Attribution CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/deed.en) .Published by the American Physiological Society. | en_US |
dc.rights | The following publication Barathi, V. A., Katz, A., Chaudhary, S., Li, H. L., Tal, D. M., Marcovich, A., ... & Karlish, S. J. (2024). A digoxin derivative that potently reduces intraocular pressure: efficacy and mechanism of action in different animal models. American Journal of Physiology-Cell Physiology, 326(5), C1505-C1519 is available at https://doi.org/10.1152/ajpcell.00617.2023. | en_US |
dc.subject | Digoxin derivative (DcB) | en_US |
dc.subject | Glaucoma | en_US |
dc.subject | Na,K-ATPase | en_US |
dc.subject | Ocular hypertension | en_US |
dc.title | A digoxin derivative that potently reduces intraocular pressure : efficacy and mechanism of action in different animal models | en_US |
dc.type | Journal/Magazine Article | en_US |
dc.identifier.spage | C1505 | en_US |
dc.identifier.epage | C1519 | en_US |
dc.identifier.volume | 326 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.doi | 10.1152/ajpcell.00617.2023 | en_US |
dcterms.abstract | Glaucoma is a blinding disease. Reduction of intraocular pressure (IOP) is the mainstay of treatment, but current drugs show side-effects or become progressively ineffective, highlighting the need for novel compounds. We have synthesized a family of perhydro-1,4-oxazepine derivatives of digoxin, the selective inhibitor of Na,K-ATPase. The cyclobutyl derivative (DcB) displays strong selectivity for the human a2 isoform and potently reduces IOP in rabbits. These observations appeared consistent with a hypothesis that in ciliary epithelium DcB inhibits the a2 isoform of Na,K-ATPase, which is expressed strongly in non-pigmented cells, reducing aqueous humor (AH) inflow. This paper extends assessment of efficacy and mechanism of action of DcB using an ocular hypertensive non-human primate model (OHT-NHP) (Macaca fascicularis). In OHT-NHP, DcB potently lowers IOP, in both acute (24 hour) and extended (7-10 day) settings, accompanied by increased aqueous humor flow rate (AFR). By contrast, ocular normotensive animals (ONT-NHP) are poorly responsive to DcB, if at all. The mechanism of action of DcB has been analyzed using isolated porcine ciliary epithelium and perfused enucleated eyes to study AH inflow and AH outflow facility, respectively. (1) DcB significantly stimulates AH inflow although prior addition of 8-Br-cAMP, which raises AH inflow, precludes additional effects of DcB. (2) DcB significantly increases AH outflow facility via the trabecular meshwork (TM). Taken together, the data indicates that the original hypothesis on the mechanism of action must be revised. In the OHT-NHP, and presumably other species, DcB lowers IOP by increasing AH outflow facility rather than by decreasing AH inflow. | en_US |
dcterms.accessRights | open access | en_US |
dcterms.bibliographicCitation | American journal of physiology. Cell physiology, May 2024, v. 326, no. 5, p. C1505-C1519 | en_US |
dcterms.isPartOf | American journal of physiology. Cell physiology | en_US |
dcterms.issued | 2024-05 | - |
dc.identifier.eissn | 1522-1563 | en_US |
dc.description.validate | 202404 bcch | en_US |
dc.description.oa | Version of Record | en_US |
dc.identifier.FolderNumber | a2674, a2770 | - |
dc.identifier.SubFormID | 48044, 48283 | - |
dc.description.fundingSource | Others | en_US |
dc.description.fundingText | This work was funded by research grants from the YEDA corporation, and a donation from 788 Les.E and Cyndy Lederer, at the Weizmann Institute of Science (SJDK); Health and Medical 789 Research Fund (20212781), Region government (CWD). InnoHK initiative and the Hong Kong 790 Special Administrative Region Government (CWD), 1-CD65 (CWD). | en_US |
dc.description.pubStatus | Published | en_US |
dc.description.oaCategory | CC | en_US |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Barathi_Digoxin_Derivative_Potently .pdf | 4.99 MB | Adobe PDF | View/Open |
Page views
25
Citations as of Jun 30, 2024
Downloads
6
Citations as of Jun 30, 2024
![](/image/google_scholar.jpg)
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.